Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) and AbbVie (NYSE:ABBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Insider and Institutional Ownership 70.2% of AbbVie shares are […]
Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) shot up 23.3% during mid-day trading on Wednesday . The company traded as high as C$64.90 and last traded at C$64.90. 1,000 shares changed hands during trading, an increase of 150% from the average session volume of 400 shares. The stock had previously closed at C$52.65. Cosmo Pharmaceuticals […]
Winlevi is a first-in-class topical drug for the treatment of acne approved by U.S. FDA in August 2020.It will reinforce our Proprietary Brand segment's dermatological franchise. SINGAPORE,